Physician profile
Fred V Lause
NPI 1487703195
$534.87
in general payments reported to CMS, 2019-2025
11 companies · $17.40 in 2025
The $17.40 reported for 2025 was less than what a typical Foot & Ankle Surgery provider received nationally (typical 2025 total: $424).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $68.80 · 2020: $224 · 2021: $39.66 · 2022: $28.79 · 2024: $157 · 2025: $17.40.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $174.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $173.98 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Tactile Systems Technology INC | $183.96 | 2019-2020 | |
| Paragon 28, INC. | $148.16 | 2024 | Precision Mis Bunion |
| Kci USA, INC. | $60.83 | 2020 | |
| Organogenesis INC. | $27.95 | 2021 | |
| Wright Medical Technology, INC. | $25.27 | 2019 | |
| Smith+Nephew, INC. | $22.38 | 2020 | |
| Globus Medical, INC. | $17.40 | 2025 | Senza |
| Ortho Dermatologics, A Division of Bausch Health US, LLC | $15.44 | 2022 | |
| Stryker Corporation | $13.35 | 2022 | |
| Abbvie INC. | $11.71 | 2021 | |
| Reprise Biomedical, INC. | $8.42 | 2024 | Miro3d |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Fred Lause listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.